131 related articles for article (PubMed ID: 26316212)
1. In vitro antifungal activity of antipsychotic drugs and their combinations with conventional antifungals against Scedosporium and Pseudallescheria isolates.
Homa M; Galgóczy L; Tóth E; Tóth L; Papp T; Chandrasekaran M; Kadaikunnan S; Alharbi NS; Vágvölgyi C
Med Mycol; 2015 Nov; 53(8):890-5. PubMed ID: 26316212
[TBL] [Abstract][Full Text] [Related]
2. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Gilgado F; Serena C; Cano J; Gené J; Guarro J
Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Scedosporium isolates to N-acetyl-L-cysteine alone and in combination with conventional antifungal agents.
Homa M; Galgóczy L; Tóth E; Virágh M; Chandrasekaran M; Vágvölgyi C; Papp T
Med Mycol; 2016 Oct; 54(7):776-9. PubMed ID: 27143635
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Schemuth H; Dittmer S; Lackner M; Sedlacek L; Hamprecht A; Steinmann E; Buer J; Rath PM; Steinmann J
Mycoses; 2013 May; 56(3):297-303. PubMed ID: 23170818
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
Zeng J; Kamei K; Zheng Y; Nishimura K
Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):101-4. PubMed ID: 15118667
[TBL] [Abstract][Full Text] [Related]
7. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
Cuenca-Estrella M; Ruiz-Díez B; Martínez-Suárez JV; Monzón A; Rodríguez-Tudela JL
J Antimicrob Chemother; 1999 Jan; 43(1):149-51. PubMed ID: 10381115
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.
Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2007 Feb; 51(2):748-51. PubMed ID: 17101671
[TBL] [Abstract][Full Text] [Related]
9. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Castanheira M; Duncanson FP; Diekema DJ; Guarro J; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2012 Jan; 56(1):352-7. PubMed ID: 22083469
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of conventional antifungal agents against Scedosporium apiospermum isolates recovered from clinical and environmental samples in Nigeria.
Nweze EI; Okafor JI
Acta Microbiol Immunol Hung; 2010 Sep; 57(3):209-14. PubMed ID: 20870592
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.
Cuenca-Estrella M; Alastruey-Izquierdo A; Alcazar-Fuoli L; Bernal-Martinez L; Gomez-Lopez A; Buitrago MJ; Mellado E; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2008 Mar; 52(3):1136-9. PubMed ID: 18195067
[TBL] [Abstract][Full Text] [Related]
12. In vitro interactions of amantadine hydrochloride, R-(-)-deprenyl hydrochloride and valproic acid sodium salt with antifungal agents against filamentous fungal species causing central nervous system infection.
Galgóczy L; Tóth L; Virágh M; Papp T; Vágvölgyi CS
Acta Biol Hung; 2012 Dec; 63(4):490-500. PubMed ID: 23134606
[TBL] [Abstract][Full Text] [Related]
13. Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of
Vikelouda K; Simitsopoulou M; Skoura L; Antachopoulos C; Roilides E
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0063821. PubMed ID: 34370583
[No Abstract] [Full Text] [Related]
14. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
Walsh TJ; Peter J; McGough DA; Fothergill AW; Rinaldi MG; Pizzo PA
Antimicrob Agents Chemother; 1995 Jun; 39(6):1361-4. PubMed ID: 7574531
[TBL] [Abstract][Full Text] [Related]
15. [Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
Ergin C; Kutlu M; Arıkan Akdağlı S; Sarıbaş Z; Aydeniz Ozansoy F; Sarı I; Dursunoğlu N
Mikrobiyol Bul; 2013 Apr; 47(2):351-5. PubMed ID: 23621736
[TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis.
Sun Y; Liu W; Wan Z; Wang X; Li R
Mycopathologia; 2011 Feb; 171(2):111-7. PubMed ID: 20803255
[TBL] [Abstract][Full Text] [Related]
17. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning.
Tintelnot K; Wagner N; Seibold M; de Hoog GS; Horré R
Mycoses; 2008 Sep; 51 Suppl 3():11-6. PubMed ID: 18782237
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
Compain F; Botterel F; Sitterlé E; Paugam A; Bougnoux ME; Dannaoui E
J Med Microbiol; 2015 Mar; 64(Pt 3):309-311. PubMed ID: 25596124
[No Abstract] [Full Text] [Related]
19. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.
Meletiadis J; Meis JF; Mouton JW; Rodriquez-Tudela JL; Donnelly JP; Verweij PE;
Antimicrob Agents Chemother; 2002 Jan; 46(1):62-8. PubMed ID: 11751112
[TBL] [Abstract][Full Text] [Related]
20. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
Venturini TP; Al-Hatmi AMS; Rossato L; Azevedo MI; Keller JT; Weiblen C; Santurio JM; Alves SH
Int J Antimicrob Agents; 2018 May; 51(5):784-788. PubMed ID: 29127050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
